Ring finger 220 promotes the stemness and progression of colon cancer cells via Ubiquitin specific peptidase 22-BMI1 axis

References

• Tang B, Liang W, Liao Y, et al. PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway. Oncol Rep. 2019;41(1):43–56.
   PubMed Web of Science ®Google Scholar
• Yu W, Ma Y, Shankar S, et al. SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer. Sci Rep. 2017;7(1):10939.
   PubMedGoogle Scholar
• Chen J, Zhao J, Ding J, et al. Knocking down LSD1 inhibits the stemness features of colorectal cancer stem cells. Braz J Med Biol Res = Rev Bras Pesqui Med Biol. 2020;53(7):e9230.
   PubMed Web of Science ®Google Scholar
• Xiong J, Zhang L, Tang R, et al. MicroRNA-301b-3p facilitates cell proliferation and migration in colorectal cancer by targeting HOXB1. Bioengineered. 2021;12(1):5839–5849.
   PubMed Web of Science ®Google Scholar
• Ma P, An T, Zhu L, et al. RNF220 is required for cerebellum development and regulates medulloblastoma progression through epigenetic modulation of Shh signaling. Development. 2020;147:21.
   Web of Science ®Google Scholar
• Ma P, Yang X, Kong Q, et al. The ubiquitin ligase RNF220 enhances canonical Wnt signaling through USP7-mediated deubiquitination of β-catenin. Mol Cell Biol. 2014;34(23):4355–4366.
   PubMed Web of Science ®Google Scholar
• Zhang QM, Ni WW, Li Y, et al. Analysis of altered miRNA profiling in the colon of a mouse model with β-lactoglobulin allergy. Allergol Immunopathol (Madr). 2020;48(6):666–674.
   PubMed Web of Science ®Google Scholar
• Pan Y, An N, Deng X, et al. RNF220 promotes the proliferation of leukaemic cells and reduces the degradation of the Cyclin D1 protein through USP22. Blood Cells Mol Dis. 2021;86:102490.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang Y, Li J, et al. USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4. Oncotarget. 2017;8(20):32683–32695.
   PubMedGoogle Scholar
• Ma Y, Fu HL, Wang Z, et al. USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein. Oncotarget. 2017;8(20):33329–33342.
   PubMedGoogle Scholar
• Ran Q, Jin F, Xiang Y, et al. CRIF1 as a potential target to improve the radiosensitivity of osteosarcoma. Proc Natl Acad Sci U S A. 2019;116(41):20511–20516.
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 2013;310(20):2191–2194.
   PubMed Web of Science ®Google Scholar
• Qiao L, Zheng J, Jin X, et al. Ginkgolic acid inhibits the invasiveness of colon cancer cells through AMPK activation. Oncol Lett. 2017;14(5):5831–5838.
   PubMed Web of Science ®Google Scholar
• Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nat Protoc. 2006;1(3):1559–1582.
   PubMed Web of Science ®Google Scholar
• Michaelidou K, Tzovaras A, Missitzis I, et al. The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression. Int J Oncol. 2013;42(5):1770–1777.
   PubMed Web of Science ®Google Scholar
• Qiu GZ, Liu Q, Wang XG, et al. Hypoxia-induced USP22-BMI1 axis promotes the stemness and malignancy of glioma stem cells via regulation of HIF-1α. Life Sci. 2020;247:117438.
   PubMed Web of Science ®Google Scholar
• Park S, Kim J, Eom K, et al. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer. BMC Cancer. 2019;19(1):419.
   PubMedGoogle Scholar
• Takanari H, Yamanaka H, Mitani H, et al. Replication sites as revealed by double label immunofluorescence against proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) in synchronized CHO cells and vincristine-induced multinucleate cells. Biol Cell. 1994;82(1):23–31.
   PubMed Web of Science ®Google Scholar
• Lin Q, Chen H, Zhang M, et al. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway. Biomed Pharmacothe. 2019;115:108939.
   PubMed Web of Science ®Google Scholar
• Ren J, Ding L, Zhang D, et al. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Theranostics. 2018;8(14):3932–3948.
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun Q, Mu N, et al. The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells. Cell Commun Signal. 2020;18(1):112.
   PubMed Web of Science ®Google Scholar
• McCann JJ, Vasilevskaya IA, Poudel Neupane N, et al. USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA Repair. Cancer Res. 2020;80(3):430–443.
   PubMed Web of Science ®Google Scholar
• Liu H, Liu N, Zhao Y, et al. Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling. Aging (Albany NY). 2019;11(21):9643–9660.
   PubMedGoogle Scholar
• Bai Z, Du Y, Cong L, et al. The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma. Gene. 2020;758:144960.
   PubMed Web of Science ®Google Scholar
• Kosinsky RL, Helms M, Zerche M, et al. USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer. Cell Death Dis. 2019;10(12):911.
   PubMedGoogle Scholar
• Kosinsky RL, Saul D, Ammer-Herrmenau C, et al. USP22 Suppresses SPARC Expression in Acute Colitis and Inflammation-Associated Colorectal Cancer. Cancers (Basel). 2021;13(8):8.
   Web of Science ®Google Scholar
• Yang DD, Cui BB, Sun LY, et al. The co-expression of USP22 and BMI-1 may promote cancer progression and predict therapy failure in gastric carcinoma. Cell Biochem Biophys. 2011;61(3):703–710.
   PubMed Web of Science ®Google Scholar